Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk
- PMID: 24151181
- DOI: 10.1002/mds.25717
Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk
Abstract
There is uncertainty surrounding the accuracy of prevalence estimates for Huntington's disease (HD). The aims of this study were to provide a best estimate of the prevalence and population at risk for HD in the province of British Columbia (BC), Canada, in 2012. HD patients with a clinical and/or genetic diagnosis of HD and individuals at risk for HD were ascertained from multiple sources. Clinical and genetic data were obtained from all available medical, social service, and genetic testing records. Six hundred and thirty-one HD patients and 3,763 individuals at 25% or 50% risk for HD were identified. Prevalence of HD was estimated at 13.7 per 100,000 (95% confidence interval [CI]: 12.6-14.8 per 100,000) in the general population, and 17.2 per 100,000 (95% CI: 15.8-18.6 per 100,000) in the Caucasian population. The population at 25% to 50% risk was estimated at 81.6 per 100,000 (95% CI: 79.0-84.2 per 100,000) individuals. These figures suggest there may be up to 4,700 individuals affected with HD and 14,000 at 50% risk for HD in Canada as well as up to 43,000 individuals affected with HD and 123,000 at 50% risk for HD in the United States. This is the first direct assessment of HD epidemiology in Canada in over three decades. These findings suggest that underascertainment may have led to previous underestimates of prevalence, namely, in Caucasian populations, and will aid in the planning of appropriate resource allocation and service delivery for the HD community.
Keywords: Huntington disease; ascertainment; epidemiology; population at risk; prevalence.
Copyright © 2013 Movement Disorder Society.
Similar articles
-
Epidemiology of Huntington's disease in Slovenia.Acta Neurol Scand. 2009 Jun;119(6):371-5. doi: 10.1111/j.1600-0404.2008.01110.x. Epub 2008 Oct 22. Acta Neurol Scand. 2009. PMID: 18976322
-
Huntington disease reduced penetrance alleles occur at high frequency in the general population.Neurology. 2016 Jul 19;87(3):282-8. doi: 10.1212/WNL.0000000000002858. Epub 2016 Jun 22. Neurology. 2016. PMID: 27335115 Free PMC article.
-
An unusually low prevalence of Huntington's disease in Iceland.Eur Neurol. 2012;68(1):48-51. doi: 10.1159/000337680. Epub 2012 Jun 20. Eur Neurol. 2012. PMID: 22722209
-
[Population genetic study of Huntington's disease--prevalence and founder's effect in the San-in area, western Japan].Nihon Rinsho. 1999 Apr;57(4):900-4. Nihon Rinsho. 1999. PMID: 10222787 Review. Japanese.
-
Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review.BMJ Open. 2016 Feb 23;6(2):e009070. doi: 10.1136/bmjopen-2015-009070. BMJ Open. 2016. PMID: 26908513 Free PMC article. Review.
Cited by
-
Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose.Neurol Ther. 2023 Apr;12(2):597-617. doi: 10.1007/s40120-023-00449-w. Epub 2023 Feb 22. Neurol Ther. 2023. PMID: 36811812 Free PMC article.
-
Searching for Answers: Information-Seeking by Young People At-Risk for Huntington's Disease.J Huntingtons Dis. 2022;11(3):337-346. doi: 10.3233/JHD-210523. J Huntingtons Dis. 2022. PMID: 35570496 Free PMC article.
-
Survival of Korean Huntington's Disease Patients.J Mov Disord. 2016 Sep;9(3):166-70. doi: 10.14802/jmd.16022. Epub 2016 Sep 21. J Mov Disord. 2016. PMID: 27667189 Free PMC article.
-
Polyglutamine Repeats in Neurodegenerative Diseases.Annu Rev Pathol. 2019 Jan 24;14:1-27. doi: 10.1146/annurev-pathmechdis-012418-012857. Epub 2018 Aug 8. Annu Rev Pathol. 2019. PMID: 30089230 Free PMC article. Review.
-
Health Services in Huntington Disease: A Systematic Literature Review.Neurol Clin Pract. 2023 Feb;13(1):e200108. doi: 10.1212/CPJ.0000000000200108. Epub 2023 Jan 11. Neurol Clin Pract. 2023. PMID: 36865636 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical